06Oct 2024
Medication increases radiation therapy's efficacy for lung cancer that has progressed to brain

Medication increases radiation therapy's efficacy for lung cancer that has progressed to brain

Researchers from the University of Cincinnati have found that the drug AM-101 may enhance radiation therapy’s efficacy for lung cancer that has metastasized to the brain. By activating GABA(A) receptors, AM-101 increases autophagy in non-small cell lung cancer (NSCLC) cells, improving radiation sensitivity and patient survival. The drug may also reduce radiation doses, minimizing side effects. The team plans to begin Phase 1 clinical trials to evaluate AM-101's effectiveness in combination with radiation for treating lung cancer.

  • #oncology

Like

Save

Share